Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lesogaberan add-on to PPI in GERD
NCT00394472Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2006
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of lesogaberan in gastroesophageal reflux disease (GERD), sponsored by AstraZeneca. Started Nov 2006; status: completed.
02
Drugs
lesogaberan
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00394472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00394472.